Area of research
Oncology · Cancer Research
Research interest
Research interests include Cutaneous Melanoma Detection and Management, Cancer Genomics and Diagnostics, Melanoma and MAPK Pathways, and Lung Cancer Treatments and Mutations.
Early Detection and Prognostic Assessment of Cutaneous Melanoma
Improving Selection for Sentinel Lymph Node Biopsy Among Patients With Melanoma
Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation–Induced DNA Damage and Melanoma Susceptibility
PHIP drives glioblastoma motility and invasion by regulating the focal adhesion complex
Novel tumor suppressor role of miRNA-876 in cholangiocarcinoma
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials
PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer
Stratifying SLN incidence in intermediate thickness melanoma patients
Tumor suppressor role of microRNA-1296 in triple-negative breast cancer
The Role of BPTF in Melanoma Progression and in Response to BRAF-Targeted Therapy
Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma
Pediatric melanoma: Results of a large cohort study and proposal for modified ABCD detection criteria for children
The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression
Is Head and Neck Melanoma Different from Trunk and Extremity Melanomas with Respect to Sentinel Lymph Node Status and Clinical Outcome?
Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012”
Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective <i>BRAF</i> Inhibition
Sunitinib Therapy for Melanoma Patients with <i>KIT</i> Mutations
Metastasectomy for Distant Metastatic Melanoma: Analysis of Data from the First Multicenter Selective Lymphadenectomy Trial (MSLT-I)
Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis
Analysis of sentinel lymph node positivity in patients with thin primary melanoma